Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.97 USD

4.97
63,036

+0.02 (0.38%)

Updated Aug 21, 2026 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Quidel's (QDEL) fourth-quarter results are likely to reflect continued strength across its SARS-related products.

Zacks Equity Research

Bruker (BRKR) Q4 Earnings Meet Estimates, Revenues Surpass

by Zacks Equity Research

Robust performance by the BSI and BEST segments drove Bruker's (BRKR) fourth-quarter top line.

Zacks Equity Research

Zacks.com featured highlights include Asbury Automotive Group, Allscripts Healthcare Solutions, HarleyDavidson, AGCO and CBRE Group

by Zacks Equity Research

Asbury Automotive Group, Allscripts Healthcare Solutions, HarleyDavidson, AGCO and CBRE Group are included in this blog.

Zacks Equity Research

Here's Why You Should Retain Abiomed (ABMD) Stock For Now

by Zacks Equity Research

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

Zacks Equity Research

Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

Strength in Life Sciences segment driven by a recovery in routine testing drove Bio-Rad (BIO) top line in the fourth quarter.

Zacks Equity Research

Phibro (PAHC) Q2 Earnings Surpass Estimates, 2022 View Up

by Zacks Equity Research

Phibro (PAHC) reports better-than-expected earnings for the fiscal second quarter. Robust performances by the Animal Health and Mineral Health segments drove the top line.

Zacks Equity Research

Illumina (ILMN) Q4 Earnings Top Estimates, Gross Margin Up

by Zacks Equity Research

Record shipments for both clinical and research with strength in oncology testing, genetic disease testing, and population genomics drove Illumina (ILMN) Q4 revenues.

Zacks Equity Research

LabCorp (LH) Q4 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

LabCorp (LH) reports better-than-expected results for the fourth quarter, with solid contributions from the Drug Development business driving the top line.

Zacks Equity Research

STERIS (STE) Q3 Earnings Surpass Estimates, Revenues Miss

by Zacks Equity Research

STERIS (STE) reports better-than-expected earnings for the third quarter of fiscal 2022 and robust segmental growth driving the top line.

Zacks Equity Research

Here's Why You Should Retain Abbott (ABT) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Abbott (ABT) owing to the strength in its diagnostics business.